Document Detail

High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia.
MedLine Citation:
PMID:  11009276     Owner:  NLM     Status:  MEDLINE    
The clinical and biochemical determinants of high-density lipoprotein (HDL) and triglyceride response to simvastatin and atorvastatin were assessed in 150 patients with severe hyperlipidemia treated in a randomized open-trial format design. Triglyceride reduction was only dependent on HDL:apolipoprotein A1, change in apolipoprotein B, and dose response, whereas an increase in HDL was dependent on initial LDL, change in LDL or dose response, and therapy with simvastatin.
A S Wierzbicki; P J Lumb; G Chik; M A Crook
Related Documents :
11731186 - Estrogen/progesterone replacement versus pravastatin and their sequential association i...
3781686 - Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
15083596 - Benefits of statins in cerebrovascular disease.
19552506 - Update on patented cholesterol absorption inhibitors.
18316036 - The central type y amphipathic alpha-helices of apolipoprotein ai are involved in the m...
21915276 - Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived b...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  86     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-10-05     Completed Date:  2000-10-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  547-9, A9     Citation Subset:  AIM; IM    
Department of Chemical Pathology, King's College London, Guy's, King's & St Thomas' Medical School, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticholesteremic Agents / therapeutic use*
Cholesterol, HDL / blood*
Cross-Over Studies
Heptanoic Acids / therapeutic use*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipidemias / blood,  drug therapy
Hyperlipoproteinemia Type II / blood,  drug therapy*
Middle Aged
Pyrroles / therapeutic use*
Regression Analysis
Simvastatin / therapeutic use*
Triglycerides / blood*
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrroles; 0/Triglycerides; 110862-48-1/atorvastatin; 79902-63-9/Simvastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Should the split format in the third position of the pacemaker code be resurrected?
Next Document:  Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angiopl...